Given the role of KDM2B and PRC2 as oncogenes in brain cancer, further research should be carried out to determine whether the upregulation of KDM2B and PRC2 in glioma, GBM, and MB plays a combinatory role in the self-renewal properties of these pathologies. Here, KDM2B is linked to central nervous system cancer.